Antianemia Drug Roxadustat (FG-4592) Protects Against Doxorubicin-Induced Cardiotoxicity by Targeting Antiapoptotic and Antioxidative Pathways

Doxorubicin (DOX) is broadly used in treating various malignant tumors. However, its cardiotoxicity limits its clinical use. Roxadustat (FG-4592) is a new hypoxia-inducible factor prolyl hydroxylase (HIF-PHD) inhibitor and has been approved for treating anemia in chronic kidney diseases (CKD) patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Guangfeng, Chen, Hongbing, Wu, Mengying, Li, Yuanyuan, Gao, Ling, Huang, Songming, Zhang, Yue, Jia, Zhanjun, Xia, Weiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419679/
https://www.ncbi.nlm.nih.gov/pubmed/32848792
http://dx.doi.org/10.3389/fphar.2020.01191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419679/
https://www.ncbi.nlm.nih.gov/pubmed/32848792
http://dx.doi.org/10.3389/fphar.2020.01191

Ejemplares similares